Related Experiment Videos
Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand
Peera Buranakitjaroen1, Chaicharn Deerochanawong, Pongamorn Bunnag
1Division of Hypertension, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Prannok Rd, Bangkoknoi, Bangkok 10700, Thailand. sipbn@mahidol.ac.th
Background:
Microalbuminuria represents the earliest clinical evidence of diabetic nephropathy, and is a marker of increased cardiovascular (CV) morbidity and mortality.
Objectives:
This analysis of Thai data from the Microalbuminuria Prevalence Study (MAPS) assessed the prevalence of macroalbuminuria and microalbuminuria in hypertensive patients with type 2 diabetes.
Design:
Cross-sectional clinic-based epidemiological study.
Material And Method:
A total of 100 patients were enrolled, of which 97 patients constituted the per-protocol population (patients with bacteriuria and haematuria were excluded). Patients attended one study visit with no follow-up.
Results:
Overall, the prevalence of diabetic kidney disease was high, with macroalbuminuria contributing 13.4% [9.9-16.9; 95% confidence interval (CI)] and microalbuminuria contributing 43.3% [38.3-48.3; 95%CI].
Conclusion:
Annual screening for microalbuminuria is recommended for all patients with type 2 diabetes, as early treatment is critical for reducing CV risks. Clinical studies have shown that renin-angiotensin system inhibitors can slow the progression of diabetic nephropathy.
Insights
Diabetic kidney disease is common in hypertensive patients with type 2 diabetes. Early screening for microalbuminuria is crucial for managing cardiovascular risks and slowing disease progression.
Area of Science:
- Nephrology
- Endocrinology
- Cardiology
Background:
- Microalbuminuria is the earliest sign of diabetic nephropathy.
- It indicates increased cardiovascular morbidity and mortality risk.
Purpose of the Study:
- To assess the prevalence of macroalbuminuria and microalbuminuria.
- Focus on hypertensive patients with type 2 diabetes in Thailand.
Main Methods:
- Cross-sectional, clinic-based epidemiological study.
- 97 patients with type 2 diabetes and hypertension included.
- Exclusion criteria: bacteriuria and haematuria.
Main Results:
- High prevalence of diabetic kidney disease observed.
- Macroalbuminuria prevalence: 13.4% (95% CI: 9.9-16.9).
- Microalbuminuria prevalence: 43.3% (95% CI: 38.3-48.3).
Conclusions:
- Annual microalbuminuria screening is recommended for type 2 diabetes patients.
- Early intervention is vital for reducing cardiovascular risks.
- Renin-angiotensin system inhibitors may slow nephropathy progression.
Related Concept Videos
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Retinopathy
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes III: Clinical Manifestations